| 产品名称: | Legionella pittsburghensis |
|---|---|
| 商品货号: | TS251449 |
| <strong>Name </strong>: | Legionella pittsburghensis Pasculle et al. 1980 |
| Synonym(s) : | Tatlockia micdadei Garrity et al. 1980 Legionella micdadei Hébert et al. 1980 |
| <strong>DSM No. </strong>: | 16640, Type strain dsm-16640 dsm16640 dsm 16640 Legionella pittsburghensis |
| Strain designation : | TATLOCK |
| Other collection no. <br />or WDCM no. : | ATCC 33218, CIP 103882, NCTC 11371 |
| Isolated from : | human blood |
| Country : | United States of America |
| Date of sampling : | before 16.08.2004 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Cultivation conditions : | Medium 585 , microaerophilic (candle jar), 37°C For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used Incubation time: 2-3 days Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (5574, 9312). Sequence accession no. AF227162. (Medium 585, 37°C, microaerophilic (candle jar)). For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used. |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 5574, 9312 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 |
| Other cultures : | All DSMZ cultures of the species |
| 产品名称: | Legionella pittsburghensis |
|---|---|
| 商品货号: | TS251449 |
| <strong>Name </strong>: | Legionella pittsburghensis Pasculle et al. 1980 |
| Synonym(s) : | Tatlockia micdadei Garrity et al. 1980 Legionella micdadei Hébert et al. 1980 |
| <strong>DSM No. </strong>: | 16640, Type strain dsm-16640 dsm16640 dsm 16640 Legionella pittsburghensis |
| Strain designation : | TATLOCK |
| Other collection no. <br />or WDCM no. : | ATCC 33218, CIP 103882, NCTC 11371 |
| Isolated from : | human blood |
| Country : | United States of America |
| Date of sampling : | before 16.08.2004 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Cultivation conditions : | Medium 585 , microaerophilic (candle jar), 37°C For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used Incubation time: 2-3 days Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (5574, 9312). Sequence accession no. AF227162. (Medium 585, 37°C, microaerophilic (candle jar)). For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used. |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 5574, 9312 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 |
| Other cultures : | All DSMZ cultures of the species |